235 related articles for article (PubMed ID: 8882472)
1. Clinical features of ulcerative colitis in Korea.
Park SM; Han DS; Yang SK; Hong WS; Min YI
Korean J Intern Med; 1996 Jan; 11(1):9-17. PubMed ID: 8882472
[TBL] [Abstract][Full Text] [Related]
2. Different therapy for different types of ulcerative colitis in China.
Jiang XL; Cui HF
World J Gastroenterol; 2004 May; 10(10):1513-20. PubMed ID: 15133864
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis.
Walker AM; Szneke P; Bianchi LA; Field LG; Sutherland LR; Dreyer NA
Am J Gastroenterol; 1997 May; 92(5):816-20. PubMed ID: 9149192
[TBL] [Abstract][Full Text] [Related]
4. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis?
Jo Y; Matsumoto T; Mibu R; Iida M
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652
[TBL] [Abstract][Full Text] [Related]
5. Ulcerative colitis in Thailand: a clinical study and long term follow-up.
Pongprasobchai S; Manatsathit S; Leelakusolvong S; Sattawatthamrong Y; Boonyapisit S
J Med Assoc Thai; 2001 Sep; 84(9):1281-8. PubMed ID: 11800302
[TBL] [Abstract][Full Text] [Related]
6. Presenting features and disease course of pediatric ulcerative colitis.
Aloi M; D'Arcangelo G; Pofi F; Vassallo F; Rizzo V; Nuti F; Di Nardo G; Pierdomenico M; Viola F; Cucchiara S
J Crohns Colitis; 2013 Dec; 7(11):e509-15. PubMed ID: 23583691
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index.
Seo M; Okada M; Yao T; Matake H; Maeda K
J Gastroenterol; 2002 Jan; 37(1):29-34. PubMed ID: 11824797
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong.
Lok KH; Hung HG; Ng CH; Kwong KC; Yip WM; Lau SF; Li KK; Li KF; Szeto ML
J Gastroenterol Hepatol; 2008 Mar; 23(3):406-10. PubMed ID: 17623033
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis.
Lee HJ; Jung ES; Lee JH; Hong SP; Kim TI; Kim WH; Cheon JH
Hepatogastroenterology; 2012; 59(117):1415-20. PubMed ID: 22683958
[TBL] [Abstract][Full Text] [Related]
11. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
[TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitis.
Burri E; Beglinger C; von Felten S; Lehmann FS
Dig Dis Sci; 2015 Feb; 60(2):485-91. PubMed ID: 25344905
[TBL] [Abstract][Full Text] [Related]
13. Baseline risk assessment of patients with ulcerative colitis: does initial treatment selection influence outcomes?
Mosli M; Alfaer S; Almalaki T; Albeshry A; Aljehani S; Alshmrani B; Habib Z; Jawa H; Qari Y
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):80-85. PubMed ID: 30199472
[TBL] [Abstract][Full Text] [Related]
14. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.
Gustavsson A; Halfvarson J; Magnuson A; Sandberg-Gertzén H; Tysk C; Järnerot G
Am J Gastroenterol; 2007 Nov; 102(11):2513-9. PubMed ID: 17680849
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and natural history of ulcerative colitis in Korea.
Park SH; Kim YM; Yang SK; Kim SH; Byeon JS; Myung SJ; Cho YK; Yu CS; Choi KS; Chung JW; Kim B; Choi KD; Kim JH
Inflamm Bowel Dis; 2007 Mar; 13(3):278-83. PubMed ID: 17206722
[TBL] [Abstract][Full Text] [Related]
16. Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitis.
Andrew RE; Lauria A; Puleo FJ; Berg A; Stewart DB
J Surg Res; 2017 Nov; 219():18-24. PubMed ID: 29078879
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis.
Chen QK; Yuan SZ; Wen ZF; Zhong YQ; Li CJ; Wu HS; Mai CR; Xie PY; Lu YM; Yu ZL
World J Gastroenterol; 2005 Apr; 11(16):2462-6. PubMed ID: 15832418
[TBL] [Abstract][Full Text] [Related]
18. [Relapse rates of ulcerative colitis in remission and factors related to relapse].
Park BJ; Lee KJ; Hwang JC; Sin SJ; Chung JY; Cho SW
Korean J Gastroenterol; 2008 Jul; 52(1):21-6. PubMed ID: 19077487
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis of ulcerative colitis and its temporal change between 1977 and 2013: a hospital-based cohort study from Korea.
Lee HS; Park SH; Yang SK; Lee J; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Yea BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
J Crohns Colitis; 2015 Feb; 9(2):147-55. PubMed ID: 25518059
[TBL] [Abstract][Full Text] [Related]
20. Management of acute severe ulcerative colitis in children.
Siow VS; Bhatt R; Mollen KP
Semin Pediatr Surg; 2017 Dec; 26(6):367-372. PubMed ID: 29126505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
